Promising therapies in multiple myeloma-Reference-Cited by-同舟云学术

Promising therapies in multiple myeloma

Published:2015-07-16 Issue:3 Volume:126 Page:300-310
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Bianchi Giada¹,Richardson Paul G.¹,Anderson Kenneth C.¹

Affiliation:

1. LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/126/3/300/1390783/300.pdf

Reference124 articles.

1. Multiple myeloma.;Kyle;Blood,2008

2. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome.;Attal;N Engl J Med,1996

3. Improved survival in multiple myeloma and the impact of novel therapies.;Kumar;Blood,2008

4. Antitumor activity of thalidomide in refractory multiple myeloma.;Singhal;N Engl J Med,1999

5. A phase 2 study of bortezomib in relapsed, refractory myeloma.;Richardson;N Engl J Med,2003

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Delivery Strategies for Multiple Myeloma and Their Adverse Drug Reactions;Pharmaceuticals;2024-06-25

2. BCMA-targeted bortezomib nanotherapy improves therapeutic efficacy, overcomes resistance, and modulates the immune microenvironment in multiple myeloma;Blood Cancer Journal;2023-12-11

3. Evidence-based mechanisms of synergy with IMiD agent-based combinations in multiple myeloma;Critical Reviews in Oncology/Hematology;2023-08

4. Dual targeting of protein translation and nuclear protein export results in enhanced antimyeloma effects;Blood Advances;2023-06-27

5. A novel glycolysis-related gene signature for predicting the prognosis of multiple myeloma;Frontiers in Cell and Developmental Biology;2023-06-02